Volume | 0 |
|
|||||
News | - | ||||||
Day High | Low High |
||||||
Day Low |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Phio Pharmaceuticals Corporation | PHIO | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
0.776 |
Trades | Volume | Avg Volume | 52 Week Range |
---|---|---|---|
0 | 0 | - | 0.50 - 4.10 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
- | 0 | $ 0.776 | USD |
Phio Pharmaceuticals Corporation Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
1.91M | 2.44M | - | 0 | -10.83M | -4.43 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Phio Pharmaceuticals News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical PHIO Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 0.7664 | 0.79 | 0.73 | 0.7736195 | 24,807 | 0.0096 | 1.25% |
1 Month | 0.70 | 0.948899 | 0.6512 | 0.7919239 | 132,142 | 0.076 | 10.86% |
3 Months | 0.91 | 1.15 | 0.604849 | 0.8446128 | 338,505 | -0.134 | -14.73% |
6 Months | 0.9435 | 2.09 | 0.50 | 1.14 | 531,354 | -0.1675 | -17.75% |
1 Year | 3.95 | 4.10 | 0.50 | 1.83 | 525,456 | -3.17 | -80.35% |
3 Years | 26.64 | 29.64 | 0.50 | 14.53 | 674,514 | -25.86 | -97.09% |
5 Years | 5.748 | 130.20 | 0.50 | 19.05 | 725,305 | -4.97 | -86.50% |
Phio Pharmaceuticals Description
Phio Pharmaceuticals Corp is a US-based biotechnology company. It is principally engaged in developing immuno-oncology therapeutics based on its proprietary self-delivering RNAi platform and Samcyprone, a topical immunomodulator, which addresses significant unmet medical needs. The company's pipeline products include PH-762, PH-804, PH-790, and others. |